← Back
Research Paper
Volume 13, Issue 6
pp 8975—8988
PARP inhibitors in breast and ovarian cancer with BRCA mutations: a meta-analysis of survival
+
−
Reset
Figure 4.
Efficacy of each PARPi in breast and ovarian cancer patients with BRCAm.